South Africa will have to buy doses of Oxford-AstraZeneca's Covid-19 vaccine at a price nearly 2.5 times higher than most European countries, the country's health ministry has said.
The African continent's worst virus-hit country has ordered at least 1.5m shots of the vaccine from the Serum Institute of India (SII), expected in January and February.
A senior health official on Thursday told AFP those doses would cost $5.25 (€4.32) each – nearly two and a half times the amount paid by most European countries.
European Union members will pay $2.16 (€1.78) for AstraZeneca's shots, according to information leaked by a Belgian minister on Twitter.
AstraZeneca France told AFP in November that its shots would be capped at €2.50 (around $3) per dose "to provide vaccines to the widest population, with as fair access as possible".
It did not immediately respond to requests for comment on the health ministry's price quote.
To date South Africa has recorded more than 1.3 million cases of coronavirus and 38,800 deaths.
South Africa's deputy director general of health Anban Pillay said via text message:
"The National Department of Health confirms that the price $5.25 is what was quoted to us."
Pillay told the local Business Daynewspaper the higher price was because other countries contributed to research and development.
"The explanation we were given for why other high-income countries have a lower price is that they have invested in the [research and development], hence the discount on the price," Pillay said.
Around 2,000 South Africans participated in clinical trials for the vaccine in 2020.
South Africa paying more than double EU price for Oxford vaccine
Health ministry quotes says premium is because government did not pay into research and development effort
www.theguardian.com